Gossamer Bio Inc. [NASDAQ: GOSS] stock went on a downward path that fall over -4.05% on Wednesday, amounting to a one-week price decrease of less than -6.21%.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Over the last 12 months, GOSS stock dropped by -81.62%. The one-year Gossamer Bio Inc. stock forecast points to a potential upside of 77.63. The average equity rating for GOSS stock is currently 2.10, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $157.75 million, with 91.18 million shares outstanding and 89.93 million shares in the current float. Compared to the average trading volume of 6.03M shares, GOSS stock reached a trading volume of 3358123 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Gossamer Bio Inc. [GOSS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GOSS shares is $7.42 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GOSS stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Gossamer Bio Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 01, 2023. The new note on the price target was released on December 07, 2022, representing the official price target for Gossamer Bio Inc. stock. On December 07, 2022, analysts decreased their price target for GOSS shares from 18 to 2.
The Average True Range (ATR) for Gossamer Bio Inc. is set at 0.22 The Price to Book ratio for the last quarter was 2.68, with the Price to Cash per share for the same quarter was set at 3.20.
GOSS Stock Performance Analysis:
Gossamer Bio Inc. [GOSS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.21. With this latest performance, GOSS shares dropped by -30.25% in over the last four-week period, additionally sinking by -87.82% over the last 6 months – not to mention a drop of -81.62% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GOSS stock in for the last two-week period is set at 29.55, with the RSI for the last a single of trading hit 22.53, and the three-weeks RSI is set at 31.93 for Gossamer Bio Inc. [GOSS]. The present Moving Average for the last 50 days of trading for this stock 2.2000, while it was recorded at 1.7240 for the last single week of trading, and 8.2186 for the last 200 days.
Insight into Gossamer Bio Inc. Fundamentals:
Return on Equity for this stock declined to -105.85, with Return on Assets sitting at -53.00.
Gossamer Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.90 and a Current Ratio set at 5.90.
GOSS Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GOSS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Gossamer Bio Inc. go to 5.20%.
Gossamer Bio Inc. [GOSS] Insider Position Details
There are presently around $173 million, in the hands of institutional investors. The top three institutional holders of GOSS stocks are: STATE STREET CORP with ownership of 27,843,985, which is approximately 637.022% of the company’s market cap and around 1.20% of the total institutional ownership; VANGUARD GROUP INC, holding 7,959,857 shares of the stock with an approximate value of $13.21 million in GOSS stocks shares; and BLACKROCK INC., currently with $8.99 million in GOSS stock with ownership of nearly -1.728% of the company’s market capitalization.
Positions in Gossamer Bio Inc. stocks held by institutional investors increased at the end of Friday and at the time of the Friday reporting period, where 75 institutional holders increased their position in Gossamer Bio Inc. [NASDAQ:GOSS] by around 51,489,877 shares. Additionally, 94 investors decreased positions by around 33,546,669 shares, while 14 investors held positions by with 18,900,007 shares. The mentioned changes placed institutional holdings at 103,936,553 shares, according to the latest SEC report filing. GOSS stock had 23 new institutional investments in for a total of 2,712,012 shares, while 60 institutional investors sold positions of 21,544,950 shares during the same period.